reported some functional improvement in upper limb coordination in three of seven patients with Friedreich's Ataxia, four of six patients with primary cerebellar degeneration and three of seven patients with mixed ataxia, after twelve weeks of oral choline chloride supplements. More recently, Pentland et al, (1981) failed to demonstrate any significant difference in upper limb functions (timed handwriting, spiral drawing and rapid repetitive finger movements) in twelve patients with Friedreich's Ataxia supplemented with pure lecithin during the first and the third month of a threemonth period.
The present study was initiated in the early months of 1980 and terminated in the summer of 1981. Twenty-two patients with Friedreich's Ataxia and ten normal controls were given oral supplements of either lecithin or placebo in a double-blind crossover study which aimed at confirming previously published reports, stating some clinical improvements in muscle strength and coordination after lecithin therapy.
A detailed description of the patients, materials and methods will be found in the previous paper of this issue. We wish to report here the results of a thorough clinical appraisal and discuss the effect of lecithin on some specific clinical features of Friedreich's Ataxia.
RESULTS
The data were gathered according to group assignation (A or B) and functional stages (0 to V). The abbreviations used in the text and table are as follows: A and B refer to patients THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES group; cA and cB to controls for respective group; 1 or r to left or right; L to lecithin and P to placebo (which was made of a linoleic acid-rich preparation of safflower oil). I refers to improved, W to worsened and S to stable. a) Joint mobility and musculoskeletal deformities We observed very little change in the degree of amplitude of the four joints studied (tables la and lb). Flexion of the shoulder and flexion of the first toe were reduced during the second sixmonth period in both groups whether on lecithin or safflower oil. No noticeable deformities were observed in any patient during the twelve-month therapeutic trial.
b) Muscle function
Results of the semi-quantitative evaluation of muscle strength are shown in tables Ila and lib. Safflower oil was more effective than lecithin in stabilizing the muscular performance in both groups: A and B and in stage I and II patients.
Results of the dynamometer studies are detailed in tables III to XI. Most patients improved their performance and did so to a greater extent after the second six-month period, whether on lecithin or safflower oil. Stage I patients demonstrated a significant mean improvement of 17% in muscle strength with lecithin in comparison with safflower oil ( 
d) Functional tests
The climbing and sitting tests had to be eliminated from the original battery because of difficulty in interpretation and excessive fatigue and stress for some patients.
Results of five timed functional tests which could be correlated with the results of the questionnaire are given in tables XXIII and XXIV. The minus (-) sign means improvement over the pretrial evaluation. Running without or with support deteriorated slightly with repetition. On the contrary, the "tshirt" and the "lacing" tests improved with practice. "Speech" was slightly improved in both groups of patients while on safflower oil. According to stages (table XXIV), lecithin was more effective with regards to "clothing" for stages I, II and III, while safflower oil was more valuable for "shoe lacing" and "speech" in stages II, III and IV.
The untimed functional tests results are given in table XXV. There was an overall loss in mean achievement for both groups. Lecithin was more effective than safflower oil in minimizing the ill-effects of the disease according to group assignation. There was however no trend towards improvement with lecithin according to stages other than stage IV.
e) Questionnaire
In answer to the questionnaire, patients in group A felt that they were improved with either supplements, while patients in group B felt deteriorated (table XXVI) . According to stages, safflower oil was subjectively more effective than lecithin. Details of the answers appear in table XXVII. Difficulties in transfer and hygiene were of major concern to patients and parents. Answers as to feelings of improvement or worsening for feeding, clothing and speech were in agreement with data gathered through quantitative tests (table XXIII) . The subjective improvement in handwriting was not in agreement with the results of the SC-SIT test (table XVIII) which showed an equal number of gain and loss.
A summary of the mean percent changes in all clinical parameters tested over a one-year period is shown in table XXVIII. This summary demon-
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Quebec Cooperative Study of Friedreich's Ataxia + 11.1% strates that only two clinical features, i.e. muscle strength and motor accuracy in the upper extremities have kept positive values in both trials of lecithin and safflower oil. There was however no evidence of significant difference between lecithin and safflower oil in the mean gain or loss in any specific clinical feature. DISCUSSION Contrary to previous reports of early and significant improvement in muscle strength and motor coordination with lecithin in patients with Friedreich's and other forms of spino-cerebellar ataxia (Barbeau, 1979 : Livingstone et al, 1981 this study failed to demonstrate any beneficial effect, in any specific clinical parameter, which could be attributed to lecithin itself. Our results have showed that some patients improved with lecithin. These patients were mostly younger individuals from functional stage I and their level of improvement never passed control values. The only patient who surpassed normal control values in some specific muscle function tests while on lecithin, was our single stage IV patient. It is difficult to conclude in favour of lecithin under these circumstances.
The usefulness of a control group in such a trial, needs to be emphasized. Although our control group was small in comparison with the number of patients followed, we have gained some precious information from their contribution. First, contrary to patients, all mean scores for tests administered to controls resulted in positive values. Second, some individual controls lost points in specific tests, after either lecithin or safflower oil, in the same way some patients did. Third, we observed no difference in mean improvement scores for controls, whether on lecithin or safflower oil. Fourth, controls as well as patients learned to improve their performance, as demonstrated by the increment of test scores at the end of the second period of the trial in both groups.
Without the control group, it would have seemed logical to conclude that lecithin led to a 56% improvement in muscle strength and a 11% gain in coordination in the upper extremities in patients with Friedreich's Ataxia (table  XXVIII) . It is however more difficult to explain why patients on safflower oil, which does not contain phosphatidyl choline, had better scores in 7 out of 11 clinical parameters tested, and demonstrated a mean of 8% less deterioration in all clinical features other than muscle strength and coordination (table XXVIII) .
Safflower oil contains 30% more linoleic acid per weight than lecithin (see previous article in this issue). The implication of linoleic acid in the composition of mitochondrial membranes and as a precursor of lipoic acid has been thoroughly reviewed by Barbeau (1980) . It has not yet been established that previous observations of clinical improvement in Friedreich's Ataxia relates to the choline moiety rather than the linoleic acid-rich composition of lecithin. In view of the associated defects in the pyruvate and alphaketoglutarate dehydrogenase enzyme systems, which rely on lipoic acid as a cofactor, it would seem possible that the previously reported improvement in symptomatology in Friedreich's Ataxia with lecithin and our observed comparable effect with safflower oil proceed from the same basic principle, i.e. increased supply of linoleic acid to mitochondrial membranes and energy metabolism.
In conclusion, this study has fulfilled its two main objectives. With regards to (1) methods of clinical assessment", we believe that metered tests and timed functional tests provided the most reliable results. As for (2) concordance between objective tests results and patient's subjective feeling of changes in their clinical status, we noticed good correlation for most functions with the exception of transfer and writing. Finally we acknowledge the need for another clinical study in which the effect of pure linoleic acid alone would be assessed in patients with Friedreich's Ataxia and normal controls.
